Newsy's Latest Health News

The FDA has authorized emergency use of Pfizer's COVID-19 vaccine for ages 12-15. A CDC advisory committee will review the data and recommend usage guidelines. Novavax plans to seek FDA approval for its vaccine by July, aiming to produce 100 million doses monthly by the end of Q3. Delays were due to raw material and equipment acquisition. Special thanks to Kaiser Health News for their coverage.

What age group has the FDA authorized Pfizer's COVID-19 vaccine for emergency use?

• 10 to 14 years

• 12 to 15 years

• 16 to 18 years

• 18 to 21 years

What is the significance of the CDC advisory committee's meeting regarding the Pfizer vaccine?

• To decide the price of the vaccine

• To recommend how the vaccine should be used for young people

• To determine the vaccine's side effects

• To approve the vaccine for adults

What is Novavax's plan regarding its COVID-19 vaccine?

• To seek FDA emergency use authorization by July

• To distribute the vaccine in Europe first

• To partner with Pfizer for distribution

• To produce a single-dose vaccine

What is a key feature of the Novavax COVID-19 vaccine?

• It requires freezing temperatures for storage

• It is a single-dose vaccine

• It only requires basic refrigeration

• It is administered orally

What challenge did Novavax face in bringing its vaccine to market?

• Lack of clinical trial data

• Acquiring raw materials and equipment

• Regulatory issues in Europe

• High production costs